Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2021 07:00 ET | Source: Recro Pharma, Inc.

Recro Appoints Laura L. Parks, Ph.D. to Board of Directors

EXTON, Pa., June 16, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
June 02, 2021 07:00 ET | Source: Recro Pharma, Inc.

Recro Expands Capabilities for Growing Clinical Trial Services (CTS) Offerings

GAINESVILLE, Ga., June 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation...
May 18, 2021 07:00 ET | Source: Recro Pharma, Inc.

Recro Enters Development Agreement With Astex Pharmaceuticals

EXTON, Pa., May 18, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
May 14, 2021 09:15 ET | Source: Recro Pharma, Inc.

Recro Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Underwriters’ Full Exercise of Option Brings Gross Proceeds to $34.5 Million EXTON, Pa., May 14, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and...
May 12, 2021 08:30 ET | Source: Recro Pharma, Inc.

Recro Announces Pricing of $30.0 Million Public Offering of Common Stock

EXTON, Pa., May 12, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
May 11, 2021 16:30 ET | Source: Recro Pharma, Inc.

Recro Announces Proposed Public Offering of Common Stock

EXTON, Pa., May 11, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
May 06, 2021 16:05 ET | Source: Recro Pharma, Inc.

Recro Reports First Quarter 2021 Financial Results

Revenues of $16.8 Million Represent an Increase of 70% Compared to Q4 2020 Revenue Multiple New Business Agreements Signed Facilities Expansion and Enhancements Continue Company to Host Conference...
April 29, 2021 16:05 ET | Source: Recro Pharma, Inc.

Recro to Report Financial Results for First Quarter 2021 on May 6

MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
April 15, 2021 07:00 ET | Source: Recro Pharma, Inc.

Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences

GAINESVILLE, Ga., April 15, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation...
April 06, 2021 07:00 ET | Source: Recro Pharma, Inc.

Recro Reports Inducement Grants for New Staff

MALVERN, Pa., April 06, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...